Comvita Limited Ordinary Shares

CVT.NZX

Consumer Staples

Comvita's origins go back to the 1960s, when research was carried out on a honey and bee products-based therapeutic product range was developed. Exports to England and California commenced in 1989. In 1990 the company was restructured and began focusing on exports to Asia. Comvita shares began quotation on the Unlisted Security Market in September 2002 and the company moved to the NZSX market in 2006.

Market Data

Price

$0.700

+0.0%
Market Cap

$90.9M

P/E Ratio

-0.5x

EPS

$-1.298

Div. Yield

0.00%

52-Week Change

+0.5%

Recent Announcements

21 Jul 2026 Sph Neutral

SPH Notice - Andrew Nicholas Barclay, Securities Holdings

Andrew Nicholas Barclay, Securities Holdings disclosed a change in substantial holding (5.869%).

21 Jul 2026 Sph Neutral

SPH Notice - PHC Investments Limited (NZCN: 5024200)

PHC Investments Limited (NZCN: 5024200) disclosed a change in substantial holding (11.739%).

20 Jul 2026 Leadership Neutral

Comvita Board and Executive Team Appointments

Comvita Limited (NZX: CVT) has appointed Julia Xu and Peter Nathan as Directors and Dr. Emma Blott as Chief Commercial Officer, effective 20 July 2026, to strengthen governance and commercial leadership for the company's growth strategy.

9 Jun 2026 Leadership Neutral

Comvita Appoints F&N Director

Comvita Limited has appointed Michael Chye Hin Fah as a Director effective 22 June 2026, nominated by Fraser and Neave, Limited (F&N) following F&N's entry as a strategic shareholder with board representation rights. Chye, currently CEO of BeerCo Limited, brings extensive governance and commercial experience across consumer and food & beverage sectors in Asia.

21 May 2026 Insider Neutral

Ongoing Disclosure Notices - Directors

Three Comvita Limited directors—Bridget Coates (Chair), Robert Major, and Michael Sang—each acquired ordinary shares on 18-May-26 by participating in the company's renounceable entitlement offer at $0.65 per share, with Coates acquiring 37,802 shares, Major acquiring 34,973 shares, and Sang acquiring 16,801 shares.

21 May 2026 Sph Neutral

SPH Notice - PHC Investments Limited

PHC Investments Limited changed substantial holding from 13.063% to 11.739%.

19 May 2026 Sph Neutral

SPH Notice - Kauri NZ Investment Limited (“Kauri NZ”)

Kauri NZ Investment Limited (“Kauri NZ”) changed substantial holding from 11.291% to 10.146%.

18 May 2026 Sph Neutral

SPH Notice - F&N Ventures Pte. Ltd. (F&N Ventures)

F&N Ventures Pte. Ltd. (F&N Ventures) disclosed a change in substantial holding (19.990%).

18 May 2026 Neutral

Capital Change Notice - Rights Offer & Placement

Comvita Limited issued 59,277,289 ordinary shares on 18 May 2026 through a rights offer (46.1 million shares at $0.65 each) and strategic placement (13.2 million shares at $0.80 each), with F&N Ventures PTE. LTD. as the sole placement participant, representing 84.01% of the company's total share class.

12 May 2026 Neutral

CVT Closes $30m Rights Offer & Confirms $10.5m Placement

Comvita Limited (NZX: CVT) successfully closed a $40.5m capital raise consisting of a $30m rights offer (69% uptake from eligible shareholders) and a $10.5m strategic placement, with Fraser and Neave Limited's subsidiary F&N Ventures acquiring a 19.99% stake as a strategic investor.

Get real-time alerts for CVT

Receive AI-powered earnings summaries and instant notifications when Comvita Limited Ordinary Shares releases results.

Register Free